Item
VITAMIN B1 (THIAMINE) MONONITRATE DC98% (10610)
Thiamine Mononitrate 98% and HPMC 2%
Nutrient / Vitamin
Attributes
- Gluten-free
- Ingredient declaration
Locations
| Location name | Address |
|---|---|
| Huazhong Pharmaceuticals Co. Ltd. | No. 118, Xianshan Road Xiangyang City, Hubei Province 441000 CHN |
| Jiangxi Tianxin Pharmaceutical Co., Ltd. | Leping Industrial Zone, Leping City Jingdezhen City, JX 333300 CHN |
Documents
| Type | Location | File name | Effective | Expiration |
|---|---|---|---|---|
| HACCP | Jiangxi Tianxin Pharmaceutical Co., Ltd. | 3rd party-Haccp doc - Prinova.pdf | 5/18/2022 | 5/17/2025 |
| HACCP | Huazhong Pharmaceuticals Co. Ltd. | 3rd party-Haccp doc - Prinova.pdf | 10/4/2022 | 10/3/2025 |
| HARPC Food Safety Plan (Item) | Huazhong Pharmaceuticals Co. Ltd. | 3rd party-Haccp doc - Prinova.pdf | 10/4/2022 | 10/3/2025 |
| Allergens | Jiangxi Tianxin Pharmaceutical Co., Ltd. | Allergens.pdf | 3/18/2024 | 3/18/2026 |
| Allergens | Huazhong Pharmaceuticals Co. Ltd. | Allergens.pdf | 6/5/2024 | 6/5/2026 |
| CoA Sample | Jiangxi Tianxin Pharmaceutical Co., Ltd. | Approved COA Template (39).pdf | 4/7/2021 | 4/7/2023 |
| CoA Sample | Huazhong Pharmaceuticals Co. Ltd. | Approved COA Template 6.pdf | 8/6/2021 | 8/6/2023 |
| WADA/NSF/NFL Statement | Huazhong Pharmaceuticals Co. Ltd. | Banned Substance 8.pdf | 8/6/2021 | 8/6/2023 |
| Country of Origin | Jiangxi Tianxin Pharmaceutical Co., Ltd. | Country of Origin.pdf | 10/20/2021 | 10/19/2024 |
| Country of Origin | Huazhong Pharmaceuticals Co. Ltd. | Country of Origin.pdf | 4/29/2022 | 4/28/2025 |
| Dietary Supplement Questionnaire | Huazhong Pharmaceuticals Co. Ltd. | Dietary Supplement Questionnaire.pdf | 10/25/2019 | 10/24/2020 |
| HACCP Process Flow Diagram | Jiangxi Tianxin Pharmaceutical Co., Ltd. | Flow Chart 46.pdf | 3/11/2020 | 3/11/2022 |
| HACCP Process Flow Diagram | Huazhong Pharmaceuticals Co. Ltd. | Flow Chart 61.pdf | 7/3/2020 | 7/3/2022 |
| Kosher | Huazhong Pharmaceuticals Co. Ltd. | Huazhong - Kosher Cert 04302021.pdf | 8/5/2020 | 4/30/2021 |
| Ingredient Statement | Jiangxi Tianxin Pharmaceutical Co., Ltd. | Ingredient Breakdown_Declaration (12).pdf | 7/24/2024 | 7/24/2027 |
| Item Questionnaire | Huazhong Pharmaceuticals Co. Ltd. | Item Questionnaire.pdf | 10/28/2019 | 10/27/2020 |
| Ingredient Statement | Huazhong Pharmaceuticals Co. Ltd. | Product Data Sheet (111).pdf | 11/12/2022 | 11/12/2023 |
| California Prop. 65 | Huazhong Pharmaceuticals Co. Ltd. | Product Data Sheet (128).pdf | 10/21/2022 | 10/20/2024 |
| Shelf Life | Jiangxi Tianxin Pharmaceutical Co., Ltd. | RE_ Jiangxi Tianxin - US Specs 1.pdf | 10/21/2020 | 10/21/2023 |
| BSE - TSE | Huazhong Pharmaceuticals Co. Ltd. | Regulatory Information Sheet (83).pdf | 8/6/2022 | 8/5/2025 |
| Vegan/Vegetarian Statement | Huazhong Pharmaceuticals Co. Ltd. | Regulatory Information Sheet (84).pdf | 8/6/2021 | 8/6/2024 |
| Safety Data Sheet (SDS) | Huazhong Pharmaceuticals Co. Ltd. | SDS (57).pdf | 11/21/2022 | 11/20/2024 |
| Safety Data Sheet (SDS) | Jiangxi Tianxin Pharmaceutical Co., Ltd. | SDS 102.pdf | 1/2/2019 | 1/1/2022 |
| Suitability Requirements | Huazhong Pharmaceuticals Co. Ltd. | Suitability Requirements.pdf | 4/4/2019 | 4/3/2022 |
| GMO | Huazhong Pharmaceuticals Co. Ltd. | Thiamine Mononitrate 98 - Huazhong - GMO.pdf | 5/22/2021 | 5/22/2023 |
| Shelf Life | Huazhong Pharmaceuticals Co. Ltd. | Thiamine Mononitrate 98 - Huazhong - Spec.pdf | 5/22/2021 | 5/22/2023 |
| GRAS/NDI/ODI Statement | Huazhong Pharmaceuticals Co. Ltd. | US Regulatory Status (3).pdf | 7/25/2023 | 7/24/2026 |
| GRAS/NDI/ODI Statement | Jiangxi Tianxin Pharmaceutical Co., Ltd. | US Regulatory Status (3).pdf | 7/25/2023 | 7/24/2026 |
| Product Specification Sheet | Huazhong Pharmaceuticals Co. Ltd. | US SPECIFICATION - 2025-02-19T154354.092.pdf | 2/19/2025 | 2/19/2028 |
| GMO | Jiangxi Tianxin Pharmaceutical Co., Ltd. | VB1 98 - Jiangxi Tianxin - GMOStatus 1.pdf | 4/17/2020 | 4/17/2022 |
